FHB
HQL

First Hawaiian Bank’s abrdn Life Sciences Investors HQL Stock Holding History

First Hawaiian Bank’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-525
Closed -$9K – 1098
2019
Q1 		$9K Hold
525
– – ﹤0.01% 1415
2018
Q4 		$8K Hold
525
– – ﹤0.01% 1513
2018
Q3 		$11K Buy
+525
New +$10.4K ﹤0.01% 1523

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

First Hawaiian Bank's HQL Position: Q2 2019 in Review

First Hawaiian Bank sold out of abrdn Life Sciences Investors (HQL) in Q2 2019, closing a stake of 525 shares — an estimated $9K sold.

First Hawaiian Bank first reported a position in HQL in Q3 2018 and held it in 3 quarters. The position peaked at $11K in Q3 2018. 55 funds tracked by Wall St. Rank hold HQL as of Q2 2019.

  • First Hawaiian Bank reported no remaining abrdn Life Sciences Investors position as of Q2 2019 after selling out during the quarter.
  • First Hawaiian Bank sold 525 abrdn Life Sciences Investors shares in Q2 2019, an estimated $9K.
  • First Hawaiian Bank first reported a position in abrdn Life Sciences Investors in Q3 2018 and held it in 3 quarters.
  • First Hawaiian Bank's abrdn Life Sciences Investors position peaked at $11K in Q3 2018.
  • 55 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.